We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Avalon Pharmaceuticals (MM) | NASDAQ:AVRX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.59 | 0 | 01:00:00 |
o Rule 13d-1(b) | |||
þ Rule 13d-1(c) | |||
o Rule 13d-1(d) |
CUSIP No.
|
05346P106
|
Page |
2
|
of |
10
|
1 |
NAMES OF REPORTING PERSONS
I.R.S. Identification Nos. of above persons (entities only) Henry Partners, L.P. 23-2888396 |
||||
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
|
||||
(a) þ | |||||
(b) o | |||||
3 | SEC USE ONLY | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | ||||
Delaware | |||||
5 | SOLE VOTING POWER | ||||
NUMBER OF | 725,000 shares | ||||
SHARES | 6 | SHARED VOTING POWER | |||
BENEFICIALLY | |||||
OWNED BY | -0- | ||||
EACH | 7 | SOLE DISPOSITIVE POWER | |||
REPORTING | |||||
PERSON | 725,000 shares | ||||
WITH | 8 | SHARED DISPOSITIVE POWER | |||
-0- | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||||
725,000 shares | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | ||||
3.5% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | ||||
PN |
CUSIP No.
|
05346P106
|
Page |
3
|
of |
10
|
1 |
NAMES OF REPORTING PERSONS
I.R.S. Identification Nos. of above persons (entities only) Matthew Partners, L.P. 23-3063303 |
||||
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
|
||||
(a) þ | |||||
(b) o | |||||
3 | SEC USE ONLY | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | ||||
Delaware | |||||
5 | SOLE VOTING POWER | ||||
NUMBER OF | 500,000 shares | ||||
SHARES | 6 | SHARED VOTING POWER | |||
BENEFICIALLY | |||||
OWNED BY | -0- | ||||
EACH | 7 | SOLE DISPOSITIVE POWER | |||
REPORTING | |||||
PERSON | 500,000 shares | ||||
WITH | 8 | SHARED DISPOSITIVE POWER | |||
-0- | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||||
500,000 shares | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | ||||
2.5% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | ||||
PN |
CUSIP No.
|
05346P106
|
Page |
4
|
of |
10
|
1 |
NAMES OF REPORTING PERSONS
I.R.S. Identification Nos. of above persons (entities only) Henry Investment Trust, L.P. 23-2887157 |
||||
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
|
||||
(a) þ * | |||||
(b) o | |||||
3 | SEC USE ONLY | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | ||||
Delaware | |||||
5 | SOLE VOTING POWER | ||||
NUMBER OF | 1,225,000 shares* | ||||
SHARES | 6 | SHARED VOTING POWER | |||
BENEFICIALLY | |||||
OWNED BY | -0- | ||||
EACH | 7 | SOLE DISPOSITIVE POWER | |||
REPORTING | |||||
PERSON | 1,225,000 shares* | ||||
WITH | 8 | SHARED DISPOSITIVE POWER | |||
-0- | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||||
1,225,000 shares* | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) | ||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | ||||
6.0%* | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | ||||
PN |
Schedule 13G | Page 5 of 10 | |
CUSIP No.
|
05346P106
|
Item 1. |
(a) | Name of Issuer: | ||
Avalon Pharmaceuticals, Inc. | |||
(b) | Address of Issuers Principal Executive Offices: |
Item 2. |
(a) | Name of Person Filing: |
(1) | Henry Partners, L.P. | ||
(2) | Matthew Partners, L.P. | ||
(3) | Henry Investment Trust, L.P. |
(b) | Address of Principal Business Office, if none, Residence: |
(1) |
255 South 17
th
Street, Suite 2608
Philadelphia, PA 19103 |
||
(2) |
255 South 17
th
Street, Suite 2608
Philadelphia, PA 19103 |
||
(3) |
255 South 17
th
Street, Suite 2608
Philadelphia, PA 19103 |
(c) | Citizenship: |
(1) | Delaware | ||
(2) | Delaware | ||
(3) | Pennsylvania |
(d) | Title of Class of Securities: | ||
Common Stock, $.01 par value per share | |||
(e) | CUSIP Number: | ||
05346P106 |
Item 3. | If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: |
(a) | o Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o). | ||
(b) | o Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c). |
Schedule 13G | Page 6 of 10 | |
CUSIP No.
|
05346P106
|
(c) | o Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c). | ||
(d) | o Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). | ||
(e) | o An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E). | ||
(f) | o An employee benefit plan or endowment fund in accordance with §240.13d-(b)(1)(ii)(F). | ||
(g) | o A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G). | ||
(h) | o A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813). | ||
(i) |
o
A church plan that is excluded from the definition of an
investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15
U.S.C. 80a-3).
|
||
(j) | o A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). | ||
(k) | o Group, in accordance with §240.13d-(b)(1)(ii)(K). |
Item 4. | Ownership |
(a) | Amount beneficially owned: |
(1) | 725,000 | ||
(2) | 500,000 | ||
(3) 1,225,000 (HIT may be deemed a beneficial owner of the shares held by Henry Partners, L.P. and Matthew Partners, L.P. solely because it is the general partner of those partnerships) |
(b) | Percent of Class: |
(1) | 3.5% | ||
(2) | 2.5% | ||
(3) | 6.0% |
Schedule 13G | Page 7 of 10 | |
CUSIP No.
|
05346P106
|
(c) | Number of Shares as to which the person has: |
i. | Sole power to vote or to direct the vote: |
(1) | 725,000 | ||
(2) | 500,000 | ||
(3) | 1,225,000 (HIT may be deemed a beneficial owner of the shares held by Henry Partners, L.P. and Matthew Partners, L.P. solely because it is the general partner of those partnerships) |
ii. | Shared power to vote or to direct the vote: |
(1) | -0- | ||
(2) | -0- | ||
(3) | -0- |
iii. | Sole power to dispose or to direct the disposition of: |
(1) | 725,000 | ||
(2) | 500000 | ||
(3) 1,225,000 (HIT may be deemed a beneficial owner of the shares held by Henry Partners, L.P. and Matthew Partners, L.P. solely because it is the general partner of those partnerships) |
iv. | Shared power to dispose or to direct the disposition of: |
(1) | -0- | ||
(2) | -0- | ||
(3) | -0- |
Item 5. | Ownership of Five Percent or Less of a Class |
Item 6. | Ownership of More than Five Percent on Behalf of Another Person |
Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person |
Schedule 13G | Page 8 of 10 | |
CUSIP No.
|
05346P106
|
Item 8. | Identification and Classification of Member of the Group | |
Not applicable. |
Item 9. | Notice of Dissolution of Group | |
Not applicable. |
Item 10. | Certification | |
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. |
Schedule 13G | Page 9 of 10 | |
CUSIP No.
|
05346P106
|
HENRY PARTNERS, L.P. by its General Partner, | ||||
HENRY INVESTMENT TRUST, L.P., by its
General Partner, CANINE PARTNERS, LLC |
||||
Date: February 9, 2009 | By: | /s/ David W. Wright | ||
David W. Wright, | ||||
President | ||||
MATTHEW PARTNERS, L.P. by its General Partner, | ||||
HENRY INVESTMENT TRUST, L.P., by its
General Partner, CANINE PARTNERS, LLC |
||||
Date: February 9, 2009 | By: | /s/ David W. Wright | ||
David W. Wright, | ||||
President | ||||
HENRY INVESTMENT TRUST, L.P., by its | ||||
General Partner, CANINE PARTNERS, LLC
|
||||
Date: February 9, 2009 | By: | /s/ David W. Wright | ||
David W. Wright, | ||||
President | ||||
Schedule 13G | Page 10 of 10 | |
CUSIP No.
|
05346P106
|
HENRY PARTNERS, L.P., by its General Partner, | ||||
HENRY INVESTMENT TRUST, L.P., by its
General Partner, CANINE PARTNERS, LLC |
||||
By: | /s/ David W. Wright | |||
David W. Wright, | ||||
President | ||||
MATTHEW PARTNERS, L.P., by its General Partner, | ||||
HENRY INVESTMENT TRUST, L.P., by its
General Partner, CANINE PARTNERS, LLC |
||||
By: | /s/ David W. Wright | |||
David W. Wright, | ||||
President | ||||
HENRY INVESTMENT TRUST, L.P., by its | ||||
General Partner, CANINE PARTNERS, LLC
|
||||
By: | /s/ David W. Wright | |||
David W. Wright, | ||||
President | ||||
1 Year Avalon Chart |
1 Month Avalon Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions